Group 1 - The core point of the article is that EOCON Vision Biotech (01477) experienced a significant drop of over 13% in its stock price, attributed to its removal from the Hang Seng Composite Index [1] - As of the report, the stock price was down 13.07%, trading at HKD 9.84, with a transaction volume of HKD 224 million [1] - The Hang Seng Index Company announced its semi-annual index adjustment results on August 22, with changes effective after market close on September 5 and starting on September 8 [1] Group 2 - EOCON Vision Biotech recently reported its mid-term results for 2025, showing revenue of RMB 294 million, a year-on-year increase of 75.4% [1] - The company recorded a net loss of RMB 132 million, which represents a year-on-year reduction of 12.6% [1] - The basic loss per share was reported at RMB 0.17 [1]
欧康维视生物-B跌超13% 遭剔除恒生综合指数 上半年净亏损1.32亿元